As of 2024-10-10, the Intrinsic Value of Aldeyra Therapeutics Inc (ALDX) is
-3.19 USD. This ALDX valuation is based on the model Peter Lynch Fair Value.
With the current market price of 5.22 USD, the upside of Aldeyra Therapeutics Inc is
-161.05%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-3.19 USD
Intrinsic Value
ALDX Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-3.19 - -3.19 |
-3.19 |
-161.05% |
| P/E |
(3.25) - (13.89) |
(9.00) |
-272.5% |
| DDM - Stable |
(4.84) - (17.54) |
(11.19) |
-314.4% |
| DDM - Multi |
(4.39) - (12.81) |
(6.59) |
-226.3% |
ALDX Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
310.17 |
| Beta |
3.30 |
| Outstanding shares (mil) |
59.42 |
| Enterprise Value (mil) |
254.38 |
| Market risk premium |
4.60% |
| Cost of Equity |
10.24% |
| Cost of Debt |
5.00% |
| WACC |
9.94% |